Health Care Technology

Evolent Health: Choosing How to Share Medical-Cost Risk

On November 7, 2024, Evolent Health reported third-quarter results. Revenue was $621.4 million, and Adjusted EBITDA was $31.8 million, down from $48.7 million a year earlier. The company also reported a GAAP net loss attributable to common shareholders of $31.2 million. (, release pp. 1–2, lines 16–29, 77–101.) Read case